426 related articles for article (PubMed ID: 15206920)
21. Genotypic characterization of Porphyromonas gingivalis isolated from subgingival plaque and blood sample in positive bacteremia subjects with periodontitis.
Pérez-Chaparro PJ; Gracieux P; Lafaurie GI; Donnio PY; Bonnaure-Mallet M
J Clin Periodontol; 2008 Sep; 35(9):748-53. PubMed ID: 18662301
[TBL] [Abstract][Full Text] [Related]
22. T-cell clonality to Porphyromonas gingivalis and human heat shock protein 60s in patients with atherosclerosis and periodontitis.
Yamazaki K; Ohsawa Y; Itoh H; Ueki K; Tabeta K; Oda T; Nakajima T; Yoshie H; Saito S; Oguma F; Kodama M; Aizawa Y; Seymour GJ
Oral Microbiol Immunol; 2004 Jun; 19(3):160-7. PubMed ID: 15107067
[TBL] [Abstract][Full Text] [Related]
23. The r40-kDa outer membrane protein human monoclonal antibody protects against Porphyromonas gingivalis-induced bone loss in rats.
Hamada N; Watanabe K; Tahara T; Nakazawa K; Ishida I; Shibata Y; Kobayashi T; Yoshie H; Abiko Y; Umemoto T
J Periodontol; 2007 May; 78(5):933-9. PubMed ID: 17470029
[TBL] [Abstract][Full Text] [Related]
24. Strain-dependent activation of the mouse immune response is correlated with Porphyromonas gingivalis-induced experimental periodontitis.
Wilensky A; Polak D; Awawdi S; Halabi A; Shapira L; Houri-Haddad Y
J Clin Periodontol; 2009 Nov; 36(11):915-21. PubMed ID: 19735468
[TBL] [Abstract][Full Text] [Related]
25. Targeting of Porphyromonas gingivalis with a bispecific antibody directed to FcalphaRI (CD89) improves in vitro clearance by gingival crevicular neutrophils.
Kobayashi T; Takauchi A; van Spriel AB; Vilé HA; Hayakawa M; Shibata Y; Abiko Y; van de Winkel JG; Yoshie H
Vaccine; 2004 Dec; 23(5):585-94. PubMed ID: 15542178
[TBL] [Abstract][Full Text] [Related]
26. Porphyromonas gingivalis as putative pathogen in ovine periodontitis.
Dreyer WP; Basson NJ
J Dent Assoc S Afr; 1992 Dec; 47(12):513-6. PubMed ID: 9511637
[TBL] [Abstract][Full Text] [Related]
27. Modulation of the antibody response by Porphyromonas gingivalis and Fusobacterium nucleatum in a mouse model.
Gemmell E; Bird PS; Ford PJ; Ashman RB; Gosling P; Hu Y; Seymour GJ
Oral Microbiol Immunol; 2004 Aug; 19(4):247-51. PubMed ID: 15209995
[TBL] [Abstract][Full Text] [Related]
28. Construction of novel human monoclonal antibodies neutralizing Porphyromonas gingivalis hemagglutination activity using transgenic mice expressing human Ig loci.
Shibata Y; Hosogi Y; Hayakawa M; Hori N; Kamada M; Abiko Y
Vaccine; 2005 May; 23(29):3850-6. PubMed ID: 15893624
[TBL] [Abstract][Full Text] [Related]
29. Serum C-reactive protein and immunoglobulin G antibodies to periodontal pathogens may be effect modifiers of periodontitis and hyperglycemia.
Choi YH; McKeown RE; Mayer-Davis EJ; Liese AD; Song KB; Merchant AT
J Periodontol; 2014 Sep; 85(9):1172-81. PubMed ID: 24410292
[TBL] [Abstract][Full Text] [Related]
30. Serum immunoglobulin G (IgG) and IgG subclass responses to the RgpA-Kgp proteinase-adhesin complex of Porphyromonas gingivalis in adult periodontitis.
O'Brien-Simpson NM; Black CL; Bhogal PS; Cleal SM; Slakeski N; Higgins TJ; Reynolds EC
Infect Immun; 2000 May; 68(5):2704-12. PubMed ID: 10768963
[TBL] [Abstract][Full Text] [Related]
31. Antibody reactive with Porphyromonas gingivalis serotypes K1-6 in adult and generalized early-onset periodontitis.
Califano JV; Schifferle RE; Gunsolley JC; Best AM; Schenkein HA; Tew JG
J Periodontol; 1999 Jul; 70(7):730-5. PubMed ID: 10440633
[TBL] [Abstract][Full Text] [Related]
32. Molecular mimicry of Aggregatibacter actinomycetemcomitans with beta2 glycoprotein I.
Wang D; Nagasawa T; Chen Y; Ushida Y; Kobayashi H; Takeuchi Y; Umeda M; Izumi Y
Oral Microbiol Immunol; 2008 Oct; 23(5):401-5. PubMed ID: 18793363
[TBL] [Abstract][Full Text] [Related]
33. Antibody response after single-visit full-mouth ultrasonic debridement versus quadrant-wise therapy.
Wang D; Koshy G; Nagasawa T; Kawashima Y; Kiji M; Nitta H; Oda S; Ishikawa I
J Clin Periodontol; 2006 Sep; 33(9):632-8. PubMed ID: 16856899
[TBL] [Abstract][Full Text] [Related]
34. Antibodies to periodontal pathogens are associated with coronary heart disease.
Pussinen PJ; Jousilahti P; Alfthan G; Palosuo T; Asikainen S; Salomaa V
Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1250-4. PubMed ID: 12714435
[TBL] [Abstract][Full Text] [Related]
35. The prevalence and pathogenic differences of Porphyromonas gingivalis fimA genotypes in patients with aggressive periodontitis.
Miura M; Hamachi T; Fujise O; Maeda K
J Periodontal Res; 2005 Apr; 40(2):147-52. PubMed ID: 15733149
[TBL] [Abstract][Full Text] [Related]
36. Periodontal treatment decreases levels of antibodies to Porphyromonas gingivalis and citrulline in patients with rheumatoid arthritis and periodontitis.
Okada M; Kobayashi T; Ito S; Yokoyama T; Abe A; Murasawa A; Yoshie H
J Periodontol; 2013 Dec; 84(12):e74-84. PubMed ID: 23701010
[TBL] [Abstract][Full Text] [Related]
37. Influence of periodontal disease, Porphyromonas gingivalis and cigarette smoking on systemic anti-citrullinated peptide antibody titres.
Lappin DF; Apatzidou D; Quirke AM; Oliver-Bell J; Butcher JP; Kinane DF; Riggio MP; Venables P; McInnes IB; Culshaw S
J Clin Periodontol; 2013 Oct; 40(10):907-15. PubMed ID: 23902301
[TBL] [Abstract][Full Text] [Related]
38. Host responses to recombinant hemagglutinin B of Porphyromonas gingivalis in an experimental rat model.
Katz J; Black KP; Michalek SM
Infect Immun; 1999 Sep; 67(9):4352-9. PubMed ID: 10456874
[TBL] [Abstract][Full Text] [Related]
39. Serum antibody reactivity against recombinant PrtC of Porphyromonas gingivalis following periodontal therapy.
Beikler T; Ehmke B; Wittstock M; Schmidt H; Karch H; Flemmig TF
J Periodontal Res; 2003 Jun; 38(3):276-81. PubMed ID: 12753365
[TBL] [Abstract][Full Text] [Related]
40. Immunization with Porphyromonas gingivalis cysteine protease: effects on experimental gingivitis and ligature-induced periodontitis in Macaca fascicularis.
Moritz AJ; Cappelli D; Lantz MS; Holt SC; Ebersole JL
J Periodontol; 1998 Jun; 69(6):686-97. PubMed ID: 9660338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
